These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24099345)

  • 1. Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study.
    Vashishtha R; Mohan K; Singh B; Devarapu SK; Sreenivas V; Ranjan S; Gupta D; Sinha S; Sharma SK
    BMC Infect Dis; 2013 Oct; 13():468. PubMed ID: 24099345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial.
    Gopalan N; Santhanakrishnan RK; Palaniappan AN; Menon PA; Lakshman S; Chandrasekaran P; Sivaramakrishnan GN; Reddy D; Kannabiran BP; Agiboth HKK; Krishnamoorthy V; Rathinam S; Chockalingam C; Manoharan T; Ayyamperumal M; Jayanthi N; Satagopan K; Narayanan R; Krishnaraja R; Sathiyavelu S; Kesavamurthy B; Suresh C; Selvachitiram M; Arasan G; Susaimuthu S; Rathinam P; Angamuthu P; Jayabal L; Murali L; Ramachandran R; Tripathy SP; Swaminathan S
    JAMA Intern Med; 2018 Apr; 178(4):485-493. PubMed ID: 29507938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF).
    Nabisere R; Musaazi J; Denti P; Aber F; Lamorde M; Dooley KE; Aarnoutse R; Sloan DJ; Sekaggya-Wiltshire C
    Trials; 2020 Feb; 21(1):181. PubMed ID: 32054536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
    Swaminathan S; Narendran G; Venkatesan P; Iliayas S; Santhanakrishnan R; Menon PA; Padmapriyadarsini C; Ramachandran R; Chinnaiyan P; Suhadev M; Sakthivel R; Narayanan PR
    Am J Respir Crit Care Med; 2010 Apr; 181(7):743-51. PubMed ID: 19965813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nevirapine versus efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and tuberculosis infections in India: a pilot study.
    Sinha S; Raghunandan P; Chandrashekhar R; Sharma SK; Kumar S; Dhooria S; Ekka M; Velpandian T; Ranjan S; Ahmad H; Samantaray JC; Venkatesh S; Rewari BB; Khan NH; Pandey RM
    BMC Infect Dis; 2013 Oct; 13():482. PubMed ID: 24134449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early changes in hepatic function among HIV-tuberculosis patients treated with nevirapine or efavirenz along with rifampin-based anti-tuberculosis therapy.
    Padmapriyadarsini C; Bhavani PK; Tang A; Kumar H; Ponnuraja C; Narendran G; Hannah E; Ramesh C; Chandrasekar C; Wanke C; Swaminathan S
    Int J Infect Dis; 2013 Dec; 17(12):e1154-9. PubMed ID: 24120216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.
    Swaminathan S; Padmapriyadarsini C; Venkatesan P; Narendran G; Ramesh Kumar S; Iliayas S; Menon PA; Selvaraju S; Pooranagangadevi NP; Bhavani PK; Ponnuraja C; Dilip M; Ramachandran R
    Clin Infect Dis; 2011 Oct; 53(7):716-24. PubMed ID: 21890776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trial.
    Chabala C; Turkova A; Thomason MJ; Wobudeya E; Hissar S; Mave V; van der Zalm M; Palmer M; Kapasa M; Bhavani PK; Balaji S; Raichur PA; Demers AM; Hoddinott G; Owen-Powell E; Kinikar A; Musoke P; Mulenga V; Aarnoutse R; McIlleron H; Hesseling A; Crook AM; Cotton M; Gibb DM;
    Trials; 2018 Apr; 19(1):237. PubMed ID: 29673395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Category III DOTS treatment in immunocompetent patients with tuberculosis pleural effusion.
    Sharma SK; Solanki R; Mohan A; Jain NK; Chauhan LS;
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1505-9. PubMed ID: 23044446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India.
    Madan C; Chopra KK; Satyanarayana S; Surie D; Chadha V; Sachdeva KS; Khanna A; Deshmukh R; Dutta L; Namdeo A; Shukla A; Sagili K; Chauhan LS
    PLoS One; 2018; 13(10):e0204982. PubMed ID: 30281679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatment.
    Hemanth Kumar AK; Narendran G; Kumar RS; Ramachandran G; Sekar L; Raja K; Swaminathan S
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):805-7. PubMed ID: 26056105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired rifampicin resistance in thrice-weekly antituberculosis therapy: impact of HIV and antiretroviral therapy.
    Narendran G; Menon PA; Venkatesan P; Vijay K; Padmapriyadarsini C; Ramesh Kumar S; Bhavani KP; Sekar L; Gomathi SN; Chandrasekhar C; Kumar S; Sridhar R; Swaminathan S
    Clin Infect Dis; 2014 Dec; 59(12):1798-804. PubMed ID: 25156114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
    Schnippel K; Berhanu RH; Black A; Firnhaber C; Maitisa N; Evans D; Sinanovic E
    BMC Infect Dis; 2016 Oct; 16(1):593. PubMed ID: 27769174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment.
    Bliven-Sizemore EE; Johnson JL; Goldberg S; Burman WJ; Villarino ME; Chaisson RE;
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):473-9. PubMed ID: 22325844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved tuberculosis outcomes with daily vs. intermittent rifabutin in HIV-TB coinfected patients in India.
    Jenks JD; Kumarasamy N; Ezhilarasi C; Poongulali S; Ambrose P; Yepthomi T; Devaraj C; Benson CA
    Int J Tuberc Lung Dis; 2016 Sep; 20(9):1181-4. PubMed ID: 27510243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and antiretroviral effectiveness of concomitant use of rifampicin and efavirenz for antiretroviral-naive patients in India who are coinfected with tuberculosis and HIV-1.
    Patel A; Patel K; Patel J; Shah N; Patel B; Rani S
    J Acquir Immune Defic Syndr; 2004 Sep; 37(1):1166-9. PubMed ID: 15319677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global guidelines for treatment of tuberculosis among persons living with HIV: unresolved issues.
    Kumar A; Kumar AM; Gupta D; Kanchar A; Mohammed S; Srinath S; Tripathy S; Rajasekaran S; Chan PL; Swaminathan S; Dewan PK
    Int J Tuberc Lung Dis; 2012 May; 16(5):573-8. PubMed ID: 22507931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the 6-month thrice-weekly regimen in the treatment of new sputum smear-positive pulmonary tuberculosis under clinical trial conditions.
    Banu Rekha VV; Rajaram K; Kripasankar AS; Parthasarathy R; Umapathy KC; Sheikh I; Selvakumar N; Victor M; Niruparani C; Sridhar R; Jawahar MS
    Natl Med J India; 2012; 25(4):196-200. PubMed ID: 23278775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.